The First Hospital Of Jilin University
Clinical trials sponsored by The First Hospital Of Jilin University, explained in plain language.
-
Your phone as a diabetes coach? AI trial aims to simplify blood sugar control
Disease control Recruiting nowThis study is testing whether a smartphone app powered by artificial intelligence (AI) can help people with type 2 diabetes manage their condition better than standard care. About 400 participants will either use the AI app, which gives personalized advice on medication, diet, an…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New surgery trial aims to spare rectal cancer patients from permanent stoma bags
Disease control Recruiting nowThis study is comparing two different surgical techniques for patients with low rectal cancer. The main goal is to see if a newer, two-stage surgery (TCA) results in more patients living for 3 years without needing a permanent stoma (ostomy bag) compared to the standard surgery (…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New treatment tested to clear stubborn HPV infection
Disease control Recruiting nowThis study is testing whether a liquid antibacterial treatment called Paiteling can clear persistent high-risk HPV infection from the cervix. It will involve 115 women aged 25-65 who have had the same HPV type for at least two years. Participants will apply the treatment directly…
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for keeping ovarian cancer at bay after initial treatment
Disease control Recruiting nowThis study is testing whether adding daphnetin capsules to standard chemotherapy helps control advanced ovarian cancer after initial surgery. It involves 98 patients with stage III-IV ovarian cancer who have had successful tumor removal surgery. The goal is to see if this combina…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug combo aims to protect kidneys from scarring
Disease control Recruiting nowThis study is testing whether combining two existing medicines—budesonide and ambrisentan—can help people with IgA nephropathy, a kidney disease. Researchers want to see if this combination reduces protein in urine and slows the decline of kidney function over 36 weeks. The study…
Phase: PHASE4 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New combo therapy tested to stop aggressive skin Cancer's comeback
Disease control Recruiting nowThis study is for people with a rare and aggressive type of skin cancer called mucosal melanoma who have had it surgically removed. It is testing if adding a drug called sintilimab to standard chemotherapy is better at preventing the cancer from coming back than chemotherapy alon…
Phase: PHASE2 • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for stroke patients: drug trial aims to boost recovery after standard treatment
Disease control Recruiting nowThis study is testing whether adding the drug tirofiban soon after standard clot-busting treatment helps people recover better from a stroke. It will involve over 1,000 adults who have just had a stroke and received the standard treatment. The goal is to see if this additional dr…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Simple feeding change could help critically ill patients breathe easier
Disease control Recruiting nowThis study is testing if temporarily reducing tube feeding before turning critically ill lung failure patients onto their stomachs helps them recover better. It involves 259 adults in intensive care with severe ARDS. The goal is to see if this small change in feeding timing reduc…
Phase: NA • Sponsor: The First Hospital of Jilin University • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
AI predicts deadly blood clots after lung cancer surgery
Knowledge-focused Recruiting nowThis study aims to understand what factors increase the risk of dangerous blood clots after lung cancer surgery. Researchers will follow 900 patients for 30 days after their operation, collecting health data to identify warning signs. They will use computer models (machine learni…
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC
-
Scientists hunt for hidden blood clues in brain aneurysm patients
Knowledge-focused Recruiting nowThis study aims to understand how tiny particles in the blood differ between veins and arteries in people with brain aneurysms. Researchers will collect blood from three different areas during a patient's scheduled surgery to look for protein patterns. The goal is to find markers…
Sponsor: The First Hospital of Jilin University • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:14 UTC